• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HIV 同伴支持精准匹配平台的有效性：一项随机对照试验方案。

Effectiveness of an HIV peer support precision matching platform: a randomized controlled trial protocol.

机构信息

School of Nursing, Capital Medical University, Beijing, 100069, China.

School of Nursing, Peking University, No.38 Xueyuan Rd, Haidian District, Beijing, 100191, China.

出版信息

BMC Public Health. 2024 Oct 23;24(1):2938. doi: 10.1186/s12889-024-20335-w.

DOI:10.1186/s12889-024-20335-w
PMID:39443906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11515468/
Abstract

BACKGROUND

Peer support is a promising and significant way for people living with HIV (PLWH) to improve their health outcomes. Matching PLWH with HIV peer volunteers can effectively stimulate and mobilize the function of peer support in health management. We develop the online platform Aspark, which features a precision matching function for PLWH and volunteers. This protocol provides a comprehensive overview of the randomized controlled trial design based on Aspark.

METHOD

A parallel randomized controlled trial using block randomization will be conducted at the Beijing YouAn Home of Loving Care. The intervention group (n = 70) will have access to all 12 features of Aspark, including precise volunteer matching, health management tools, drug interaction queries, and medication reminders. The control group (n = 70) will have access to two features of informational support on Aspark. The outcomes of both groups will be evaluated at baseline and at 3, 6, 9, and 12 months after platform registration. The primary outcome is perceived social support. The secondary outcomes include mental symptoms, quality of life, self-efficacy, medication adherence, and health behaviors. Linear mixed models or generalized linear mixed models will be applied to test the intervention effects.

DISCUSSION

The Aspark trial is a randomized controlled trial designed to examine the influence of a mobile health (mHealth) application that integrates peer support and precision matching to strengthen social support for PLWH in China. This trial has the potential to significantly enhance social support for PLWH while also optimizing the delivery of peer support services and fully mobilizing the role of peer support in the overall health management of PLWH.

TRIAL REGISTRATION

Clinical registration number: ChiCTR2300077454.

摘要

背景

同伴支持是提高 HIV 感染者（PLWH）健康结果的一种有前途且重要的方式。将 PLWH 与 HIV 同伴志愿者相匹配，可以有效地激发和调动同伴支持在健康管理中的作用。我们开发了在线平台 Aspark，该平台具有针对 PLWH 和志愿者的精准匹配功能。本方案提供了基于 Aspark 的随机对照试验设计的全面概述。

方法

将在北京佑安爱心家园采用区组随机化方法开展一项平行随机对照试验。干预组（n=70）将能够使用 Aspark 的全部 12 项功能，包括精准志愿者匹配、健康管理工具、药物相互作用查询和用药提醒。对照组（n=70）将能够使用 Aspark 上的两项信息支持功能。两组的结局将在平台注册后 3、6、9 和 12 个月进行评估。主要结局是感知社会支持。次要结局包括精神症状、生活质量、自我效能、药物依从性和健康行为。将应用线性混合模型或广义线性混合模型来检验干预效果。

讨论

Aspark 试验是一项随机对照试验，旨在研究一种整合同伴支持和精准匹配的移动健康（mHealth）应用程序对中国 PLWH 社会支持的影响。该试验有可能显著增强 PLWH 的社会支持，同时优化同伴支持服务的提供，并充分调动同伴支持在 PLWH 整体健康管理中的作用。

试验注册

临床试验注册号：ChiCTR2300077454。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/2dff4cb041e5/12889_2024_20335_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/87c9d2d88547/12889_2024_20335_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/85f8718d63a2/12889_2024_20335_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/7c9324c46926/12889_2024_20335_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/bdfed4474f0b/12889_2024_20335_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/ba3270e1caad/12889_2024_20335_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/c79ace931f4e/12889_2024_20335_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/0a43d1deac45/12889_2024_20335_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/67ee3ed0a282/12889_2024_20335_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/4fe062922576/12889_2024_20335_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/f7de98e04f79/12889_2024_20335_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/46e2b6d5031f/12889_2024_20335_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/ddc1368b2973/12889_2024_20335_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/9729003050b3/12889_2024_20335_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/27b5f504dffb/12889_2024_20335_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/2825fc3627fc/12889_2024_20335_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/466abd423e85/12889_2024_20335_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/2dff4cb041e5/12889_2024_20335_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/87c9d2d88547/12889_2024_20335_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/85f8718d63a2/12889_2024_20335_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/7c9324c46926/12889_2024_20335_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/bdfed4474f0b/12889_2024_20335_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/ba3270e1caad/12889_2024_20335_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/c79ace931f4e/12889_2024_20335_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/0a43d1deac45/12889_2024_20335_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/67ee3ed0a282/12889_2024_20335_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/4fe062922576/12889_2024_20335_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/f7de98e04f79/12889_2024_20335_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/46e2b6d5031f/12889_2024_20335_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/ddc1368b2973/12889_2024_20335_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/9729003050b3/12889_2024_20335_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/27b5f504dffb/12889_2024_20335_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/2825fc3627fc/12889_2024_20335_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/466abd423e85/12889_2024_20335_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7d6/11515468/2dff4cb041e5/12889_2024_20335_Fig17_HTML.jpg

相似文献

1
Effectiveness of an HIV peer support precision matching platform: a randomized controlled trial protocol.HIV 同伴支持精准匹配平台的有效性：一项随机对照试验方案。
BMC Public Health. 2024 Oct 23;24(1):2938. doi: 10.1186/s12889-024-20335-w.
2
Peers plus mobile app for treatment in HIV (PATH): protocol for a randomized controlled trial to test a community-based integrated peer support and mHealth intervention to improve viral suppression among Hispanic and Black people living with HIV.同伴加移动应用程序治疗艾滋病毒 (PATH)：一项随机对照试验的方案，旨在测试一种基于社区的综合同伴支持和移动健康干预措施，以提高感染艾滋病毒的西班牙裔和黑人生存者的病毒抑制率。
Trials. 2024 Mar 22;25(1):212. doi: 10.1186/s13063-024-08042-8.
3
Protocol of the randomized control trial: the WiseApp trial for improving health outcomes in PLWH (WiseApp).随机对照试验方案：WiseApp 试验改善 PLWH 健康结局（WiseApp）。
BMC Public Health. 2020 Nov 25;20(1):1775. doi: 10.1186/s12889-020-09688-0.
4
Run4Love, a mHealth (WeChat-based) intervention to improve mental health of people living with HIV: a randomized controlled trial protocol.Run4Love，一个基于微信的移动医疗（mHealth）干预措施，旨在改善 HIV 感染者的心理健康：一项随机对照试验方案。
BMC Public Health. 2018 Jun 26;18(1):793. doi: 10.1186/s12889-018-5693-1.
5
PEERNaija-a mobile health platform incentivizing medication adherence among youth living with HIV in Nigeria: study protocol for a randomized controlled trial.PEERNaija——一个激励尼日利亚感染艾滋病毒青年坚持服药的移动健康平台：一项随机对照试验的研究方案
Pilot Feasibility Stud. 2023 Oct 27;9(1):179. doi: 10.1186/s40814-023-01404-0.
6
Peer-led intervention for individuals with major depression: study protocol for a randomized controlled trial (SUPEERMood).同伴主导干预对重度抑郁症患者的效果：一项随机对照试验（SUPEERMood）的研究方案。
BMC Psychiatry. 2024 Sep 30;24(1):639. doi: 10.1186/s12888-024-06094-3.
7
A differentiated digital intervention to improve antiretroviral therapy adherence among men who have sex with men living with HIV in China: a randomized controlled trial.一项旨在提高中国男男性行为艾滋病感染者抗逆转录病毒治疗依从性的差异化数字干预措施：一项随机对照试验。
BMC Med. 2022 Oct 10;20(1):341. doi: 10.1186/s12916-022-02538-3.
8
PEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.PEBRA 试验 - 同伴教育协调基于偏好的 ART 服务提供模式对艾滋病毒感染者青少年和青年的病毒抑制效果：在莱索托农村地区进行的一项基于群组的随机临床试验方案。
BMC Public Health. 2020 Mar 30;20(1):425. doi: 10.1186/s12889-020-08535-6.
9
Evaluation of smartphone APP-based case-management services among antiretroviral treatment-naïve HIV-positive men who have sex with men: a randomized controlled trial protocol.基于智能手机应用的个案管理服务在初治 HIV 阳性男男性行为者中的评估：一项随机对照试验方案。
BMC Public Health. 2020 Jan 20;20(1):85. doi: 10.1186/s12889-020-8171-5.
10
Protocol of a randomized controlled trial to test the effects of client-centered Representative Payee Services on antiretroviral therapy adherence among marginalized people living with HIV.一项随机对照试验方案，旨在测试以客户为中心的代表性收款人服务对边缘化 HIV 感染者抗逆转录病毒治疗依从性的影响。
BMC Public Health. 2020 Sep 23;20(1):1443. doi: 10.1186/s12889-020-09500-z.

本文引用的文献

1
The development and evaluation of a social media-based HIV knowledge dissemination platform in China.中国一个基于社交媒体的艾滋病知识传播平台的开发与评估
Int J Nurs Sci. 2023 Jun 23;10(3):288-293. doi: 10.1016/j.ijnss.2023.06.003. eCollection 2023 Jul.
2
The effectiveness and sustainability of peer support interventions for persons living with HIV: a realist synthesis.同伴支持干预措施对 HIV 感染者的有效性和可持续性：一项实际综合研究。
BMJ Glob Health. 2023 Feb;8(2). doi: 10.1136/bmjgh-2022-010966.
3
Exploring core mental health symptoms among persons living with HIV: A network analysis.
探索HIV感染者的核心心理健康症状：一项网络分析。
Front Psychiatry. 2023 Jan 20;14:1081867. doi: 10.3389/fpsyt.2023.1081867. eCollection 2023.
4
A differentiated digital intervention to improve antiretroviral therapy adherence among men who have sex with men living with HIV in China: a randomized controlled trial.一项旨在提高中国男男性行为艾滋病感染者抗逆转录病毒治疗依从性的差异化数字干预措施：一项随机对照试验。
BMC Med. 2022 Oct 10;20(1):341. doi: 10.1186/s12916-022-02538-3.
5
Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article.探讨免疫疗法在恶性肿瘤背景下抗 HIV 感染的应用：一篇详细的综述文章。
Int Immunopharmacol. 2022 Apr;105:108580. doi: 10.1016/j.intimp.2022.108580. Epub 2022 Feb 1.
6
Quality of life in people living with HIV in Romania and Spain.罗马尼亚和西班牙艾滋病毒感染者的生活质量。
BMC Infect Dis. 2021 Sep 13;21(Suppl 2):898. doi: 10.1186/s12879-021-06567-w.
7
Continuous quality improvement (CQI) Institutionalization to reach 95:95:95 HIV targets: a multicountry experience from the Global South.持续质量改进（CQI）机构化以实现 95:95:95 HIV 目标：来自全球南方多国的经验。
BMC Health Serv Res. 2021 Jul 20;21(1):711. doi: 10.1186/s12913-021-06731-7.
8
Essential elements to elaborate a study with the (e)Delphi method.运用（电子）德尔菲法开展一项研究的基本要素。
Enferm Intensiva (Engl Ed). 2021 Apr-Jun;32(2):100-104. doi: 10.1016/j.enfie.2020.09.003. Epub 2021 May 20.
9
Psychometric properties of self-reported measures of health-related quality of life in people living with HIV: a systematic review protocol.艾滋病毒感染者健康相关生活质量自评量表的心理测量学特性的系统评价方案。
JBI Evid Synth. 2021 Oct;19(10):2829-2838. doi: 10.11124/JBIES-20-00190.
10
Cost-Effectiveness of Peer-Delivered HIV Self-Tests for MSM in Uganda.在乌干达，男男性行为者中由同伴提供的 HIV 自我检测的成本效益。
Front Public Health. 2021 Mar 17;9:651325. doi: 10.3389/fpubh.2021.651325. eCollection 2021.